INT 767 – A NOVEL DUAL FARNESOID-X RECEPTOR (FXR) AND TAKEDA G-PROTEIN-COUPLED RECEPTOR-5 (TGR5) AGONIST ATTENUATES INTESTINAL ISCHEMIA REPERFUSION INJURY. Issue 3 (September 2020)